본문 바로가기
KERD
논문KCI 등재

Magnetic Resonance Imaging in Acute Ischemic Stroke Treatment

김혜진|김나영|강현구|강동화|안성호|김범준|Steven Warach
대한뇌졸중학회 (The Korean Stroke Society)|2014.09|대한뇌졸중영문학회지 (Journal of stroke)|제16권 제3호|pp. 131-145|DOI http://dx.doi.org/10.5853/jos.2014.16.3.131

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

Magnetic resonance imageAcute ischemic strokeThrombolysis
주제분류신경과학

초록

Although intravenous administration of tissue plasminogen activator is the only proven treatment after acute ischemic stroke, there is always a concern of hemorrhagic risk after thrombolysis. Therefore, selection of patients with potential benefits in overcoming potential harms of thrombolysis is of great importance. Despite the practical issues in using magnetic resonance imaging (MRI) for acute stroke treatment, multimodal MRI can provide useful information for accurate diagnosis of stroke, evaluation of the risks and benefits of thrombolysis, and prediction of outcomes. For example, the high sensitivity and specificity of diffusion-weighted image (DWI) can help distinguish acute ischemic stroke from stroke-mimics. Additionally, the lesion mismatch between perfusion-weighted image (PWI) and DWI is thought to represent potential salvageable tissue by reperfusion therapy. However, the optimal threshold to discriminate between benign oligemic areas and the penumbra is still debatable. Signal changes of fluid-attenuated inversion recovery image within DWI lesions may be a surrogate marker for ischemic lesion age and might indicate risks of hemorrhage after thrombolysis. Clot sign on gradient echo image may reflect the nature of clot, and their location, length and morphology may provide predictive information on recanalization by reperfusion therapy. However, previous clinical trials which solely or mainly relied on perfusion-diffusion mismatch for patient selection, failed to show benefits of MRI-based thrombolysis. Therefore, understanding the clinical implication of various useful MRI findings and comprehensively incorporating those variables into therapeutic decision-making may be a more reasonable approach for expanding the indication of acute stroke thrombolysis.

Abstract

Although intravenous administration of tissue plasminogen activator is the only proven treatment after acute ischemic stroke, there is always a concern of hemorrhagic risk after thrombolysis. Therefore, selection of patients with potential benefits in overcoming potential harms of thrombolysis is of great importance. Despite the practical issues in using magnetic resonance imaging (MRI) for acute stroke treatment, multimodal MRI can provide useful information for accurate diagnosis of stroke, evaluation of the risks and benefits of thrombolysis, and prediction of outcomes. For example, the high sensitivity and specificity of diffusion-weighted image (DWI) can help distinguish acute ischemic stroke from stroke-mimics. Additionally, the lesion mismatch between perfusion-weighted image (PWI) and DWI is thought to represent potential salvageable tissue by reperfusion therapy. However, the optimal threshold to discriminate between benign oligemic areas and the penumbra is still debatable. Signal changes of fluid-attenuated inversion recovery image within DWI lesions may be a surrogate marker for ischemic lesion age and might indicate risks of hemorrhage after thrombolysis. Clot sign on gradient echo image may reflect the nature of clot, and their location, length and morphology may provide predictive information on recanalization by reperfusion therapy. However, previous clinical trials which solely or mainly relied on perfusion-diffusion mismatch for patient selection, failed to show benefits of MRI-based thrombolysis. Therefore, understanding the clinical implication of various useful MRI findings and comprehensively incorporating those variables into therapeutic decision-making may be a more reasonable approach for expanding the indication of acute stroke thrombolysis.

참고문헌 (103)

  1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group., "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995)
  2. Hacke W., "Thrombolysis with alteplase 3 to 4. 5 hours after acute ischemic stroke", N Engl J Med, 359, pp.1317~1329 (2008)
  3. Khatri R., "Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke", Neurology, 79, pp.S52~S57 (2012)
  4. Baird AE., "Magnetic resonance imaging of acute stroke", J Cereb Blood Flow Metab, 18, pp.583~609 (1998)
  5. Campbell BC., "Assessing response to stroke thrombolysis : validation of 24-hour multimodal magnetic resonance imaging", Arch Neurol, 69, pp.46~50 (2012)
  6. Lovblad KO., "Clinical experience with diffusion-weighted MR in patients with acute stroke", Am J Neuroradiol, 19, pp.1061~1066 (1998)
  7. Chalela JA., "Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome : Insights into the pathophysiology of acute stroke in the thrombolysis era", Ann Neurol, 55, pp.105~112 (2004)
  8. Schlaug G., "The ischemic penumbra : operationally defined by diffusion and perfusion MRI", Neurology, 53, pp.1528~1537 (1999)
  9. Thomalla G., "DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4. 5 h of symptom onset(PRE-FLAIR) : a multicentre observational study", Lancet Neurol, 10, pp.978~986 (2011)
  10. Neumann-Haefelin T., "Diffusion-and perfusion-weighted MRI. The DWI", PWI mismatch region in acute stroke, 1999, pp.30, 1591~1597
  11. Gibson LM., "The differential diagnosis of suspected stroke : a systematic review", J R Coll Physicians Edinb, 43, pp.114~118 (2013)
  12. Warach S., "Acute human stroke studied by whole brain echo planar diffusionweighted magnetic resonance imaging", Ann Neurol, 37, pp.231~241 (1995)
  13. Sylaja PN., "When to expect negative diffusion-weight-ed images in stroke and transient ischemic attack", Stroke, 39, pp.1898~1900 (2008)
  14. Balami JS., "Stroke syndromes and clinical management", QJM, 106, pp.607~615 (2013)
  15. Kallenberg K., "Creutzfeldt-Jakob disease : comparative analysis of MR imaging sequences", Am J Neuroradiol, 27, pp.1459~1462 (2006)
  16. Bergui M., "Progressive multifocal leukoencephalopathy : diffusion-weighted imaging and pathological correlations", Neuroradiology, 46, pp.22~25 (2004)
  17. Kang DW., "Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes", Arch Neurol, 60, pp.1730~1734 (2003)
  18. Lee DK., "Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease : early diffusion-weighted imaging study", Stroke, 36, pp.2583~2588 (2005)
  19. 방오영, "Intracranial Atherosclerosis: Current Understanding and Perspectives", 대한뇌졸중학회지, 16(1), pp.27~35 (2014), 대한뇌졸중학회[DOI]
  20. Nah HW., "Diversity of single small subcortical infarctions according to infarct location and parent artery disease : analysis of indicators for small vessel disease and atherosclerosis", Stroke, 41, pp.2822~2827 (2010)
  21. Cho AH., "Mechanism of multiple infarcts in multiple cerebral circulations on diffusion-weighted imaging", J Neurol, 254, pp.924~930 (2007)
  22. Jung JM., "Difference in infarct volume and patterns between cardioembolism and internal carotid artery disease : focus on the degree of cardioembolic risk and carotid stenosis", Cerebrovasc Dis, 29, pp.490~496 (2010)
  23. Cho KH., "Factors and outcomes associated with recanalization timing after thrombolysis", Cerebrovasc Dis, 33, pp.255~261 (2012)
  24. Cho AH., "Evaluation of early dynamic changes of intracranial arterial occlusion is useful for stroke etiology diagnosis", J Neurol Sci, 312, pp.127~130 (2012)
  25. Cho KH., "Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes", Stroke, 36, pp.2379~2383 (2005)
  26. Kim BJ., "Imaging characteristics of ischemic strokes related to patent foramen ovale", Stroke, 44, pp.3350~3356 (2013)
  27. Jung JM., "Ischemic lesion burden and characteristics of aortic atheroma", J Stroke Cerebrovasc Dis, 23, pp.278~282 (2014)
  28. Kim YS., "Public awareness of stroke in Korea : a population-based national survey", Stroke, 43, pp.1146~1149 (2012)
  29. Dirnagl U., "Pathobiology of ischaemic stroke : an integrated view", Trends Neurosci, 22, pp.391~397 (1999)
  30. Banerjee RK., "Physiological flow analysis in significant human coronary artery stenoses", Biorheology, 40, pp.451~476 (2003)
  31. Tatlisumak T., "The role of diffusion-and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke : from laboratory to clinics", Curr Vasc Pharmacol, 2, pp.343~355 (2004)
  32. 장건호, "관류 자기공명영상의 원리 및 기술", Investigative Magnetic Resonance Imaging, 15(2), pp.91~101 (2011), 대한자기공명의과학회
  33. Heo SH., "Acute cerebral infarction in a rabbit model : perfusion and diffusion MR imaging", J Korean Soc Magn Reson Med, 7, pp.116~123 (2003)
  34. 전형원, "급성기 뇌경색 환자에서 뇌 자기공명영상의 확산-관류 불일치가 임상적 예후를 예측할 수 있는가?-rCBV를 중심으로-", 대한신경과학회지, 26(4), pp.295~300 (2008), 대한신경과학회
  35. Copen WA., "MR perfusion imaging in acute ischemic stroke", Neuroimaging Clin N Am, 21, pp.259~283 (2011)
  36. Albers GW., "Magnetic resonance imaging profiles predict clinical response to early reperfusion : the diffusion and perfusion imaging evaluation for understanding stroke evolution(DEFUSE)study", Ann Neurol, 60, pp.508~517 (2006)
  37. Donnan GA., "Penumbral selection of patients for trials of acute stroke therapy", Lancet Neurol, 8, pp.261~269 (2009)
  38. Olivot JM., "Optimal Tmax threshold for predicting penumbral tissue in acute stroke", Stroke, 40, pp.469~475 (2009)
  39. Nagakane Y., "Moving beyond a single perfusion threshold to define penumbra : a novel probabilistic mismatch definition", Stroke, 43, pp.1548~1555 (2012)
  40. Albers GW., "Magnetic resonance imaging profiles predict clinical response to early reperfusion : the diffusion and perfusion imaging evaluation for understanding stroke evolution(DEFUSE)study", Ann Neurol, 60, pp.508~517 (2006)
  41. Davis SM., "Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial(EPITHET) : a placebo-controlled randomised trial", Lancet Neurol, 7, pp.299~309 (2008)
  42. Hacke W., "The Desmoteplase in Acute Ischemic Stroke Trial(DIAS) : a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase", Stroke, 36, pp.66~73 (2005)
  43. Kimura K., "Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients", J Neurol Sci, 270, pp.48~52 (2008)
  44. Fisher M., "Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction", J Neuropathol Exp Neurol, 10, pp.92~94 (1951)
  45. Ogata J., "Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke", Stroke, 20, pp.876~883 (1989)
  46. Simard JM., "Brain oedema in focal ischaemia : molecular pathophysiology and theoretical implications", Lancet Neurol, 6, pp.258~268 (2007)
  47. Burggraf D., "Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia", Thromb Haemost, 89, pp.1072~1080 (2003)
  48. Warach S., "Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption", Stroke, 35, pp.2659~2661 (2004)
  49. Hacke W., "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke(ECASS II). Second European-Australasian Acute Stroke Study Investigators", Lancet, 352, pp.1245~1251 (1998)
  50. Alvarez-Sabin J., "Factors influencing haemorrhagic transformation in ischaemic stroke", Lancet Neurol, 12, pp.689~705 (2013)
  51. The NINDS t-PA Stroke Study Group., "Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke", Stroke, 28, pp.2109~2118 (1997)
  52. Molina CA., "Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke", Stroke, 32, pp.1079~1084 (2001)
  53. Butcher K., "Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation", Stroke, 41, pp.72~77 (2010)
  54. Selim M., "Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator : prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume", Stroke, 33, pp.2047~2052 (2002)
  55. Adams HP Jr., "Guidelines for the early management of adults with ischemic stroke : a guideline from the American Heart Association", American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups : the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists, 2007, pp.38, 1655~1711
  56. Grotta JC., "Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy", Stroke, 30, pp.1528~1533 (1999)
  57. Alsop DC., "Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke", Stroke, 36, pp.746~750 (2005)
  58. Cho AH., "Focal fluid-attenuated inversion recovery hyperintensity within acute diffusion-weighted imaging lesions is associated with symptomatic intracerebral hemorrhage after thrombolysis", Stroke, 39, pp.3424~3426 (2008)
  59. Kidwell CS., "Magnetic resonance imaging detection of microbleeds before thrombolysis : an emerging application", Stroke, 33, pp.95~98 (2002)
  60. Koennecke HC., "Cerebral microbleeds on MRI : prevalence, associations, and potential clinical implications", Neurology, 66, pp.165~171 (2006)
  61. Thomalla G., "Two tales : hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia : MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours", Stroke, 38, pp.313~318 (2007)
  62. Neumann-Haefelin C., "Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism : an MRI investigation in rat brain", Stroke, 33, pp.1392~1398 (2002)
  63. Cho AH., "Reperfusion injury on magnetic resonance imaging after carotid revascularization", Stroke, 45, pp.602~604 (2014)
  64. Cho AH., "MRI evidence of reperfusion injury associated with neurological deficits after carotid revascularization procedures", Eur J Neurol, 16, pp.1066~1069 (2009)
  65. Latour LL., "Early blood-brain barrier disruption in human focal brain ischemia", Ann Neurol, 56, pp.468~477 (2004)
  66. Kim EY., "Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis : iodinated contrast media as its possible cause and the association with hemorrhagic transformation", J Comput Assist Tomogr, 29, pp.264~269 (2005)
  67. Hjort N., "MRI detection of early blood-brain barrier disruption : parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis", Stroke, 39, pp.1025~1028 (2008)
  68. Bang OY., "Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging", Ann Neurol, 62, pp.170~176 (2007)
  69. Molina CA., "Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes", Stroke, 35, pp.486~490 (2004)
  70. Kimura K., "M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke", Stroke, 40, pp.3130~3132 (2009)
  71. Riedel CH., "Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced Computed Tomography reconstructions", Stroke, 41, pp.1659~1664 (2010)
  72. Riedel CH., "The importance of size : successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length", Stroke, 42, pp.1775~1777 (2011)
  73. Zhu L., "Thrombus branching and vessel curvature are important determinants of middle cerebral artery trunk recanalization with Merci thrombectomy devices", Stroke, 43, pp.787~792 (2012)
  74. Kang DW., "Wake-up or unclearonset strokes : are they waking up to the world of thrombolysis therapy?", Int J Stroke, 7, pp.311~320 (2012)
  75. Thomalla G., "We are on the clock : MRI as a surrogate marker of lesion age in acute ischemic stroke", Stroke, 41, pp.197~198 (2010)
  76. Burdette JH., "Cerebral infarction : time course of signal intensity changes on diffusion-weighted MR images", Am J Roentgenol, 171, pp.791~795 (1998)
  77. Thomalla G., "Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less", Ann Neurol, 65, pp.724~732 (2009)
  78. Kim BJ., "Diffusion-weighted image and fluid-attenuated inversion recovery image mismatch : unclear-onset versus clear-onset stroke", Stroke, 45, pp.450~455 (2014)
  79. Kang DW., "Reperfusion therapy in unclear-onset stroke based on MRI evaluation(RESTORE) : a prospective multicenter study", Stroke, 43, pp.3278~3283 (2012)
  80. Dankbaar JW., "Age-and anatomy-related values of bloodbrain barrier permeability measured by perfusion-CT in nonstroke patients", J Neuroradiol, 36, pp.219~227 (2009)
  81. Galinovic I., "Visual and region of interest-based inter-rater agreement in the assessment of the diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch", Stroke, 45, pp.1170~1172 (2014)
  82. Kim BJ., "Color-coded FLAIR images improve inter-rater reliability of FLAIR signal changes within acute DWI lesions", Stroke, 45, pp.2801~2804 (2014)
  83. Barber PA., "Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility", Neurology, 56, pp.1015~1020 (2001)
  84. Nedeltchev K., "Outcome of stroke with mild or rapidly improving symptoms", Stroke, 38, pp.2531~2535 (2007)
  85. Kim JT., "Minor stroke with total mismatch after acute MCA occlusion", J Neuroimaging, 21, pp.399~402 (2011)
  86. Breuer L., "Off-label thrombolysis for acute ischemic stroke : rate, clinical outcome and safety are influenced by the definition of ‘minor stroke’", Cerebrovasc Dis, 32, pp.177~185 (2011)
  87. Kohrmann M., "Safety and outcome after thrombolysis in stroke patients with mild symptoms", Cerebrovasc Dis, 27, pp.160~166 (2009)
  88. Kim JT., "Internal border zone lesions as a predictor of early neurological deterioration in minor stroke patients with severe arterial steno-occlusion", J Neuroimaging, 21, pp.173~176 (2011)
  89. Johnston KC., "Validation of an acute ischemic stroke model : does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome?", Stroke, 38, pp.1820~1825 (2007)
  90. Parsons MW., "Diffusion-and perfusion-weighted MRI response to thrombolysis in stroke", Ann Neurol, 51, pp.28~37 (2002)
  91. Lansberg MG., "MRI profile and response to endovascular reperfusion after stroke(DEFUSE 2) : a prospective cohort study", Lancet Neurol, 11, pp.860~867 (2012)
  92. Khatri P., "Revascularization end points in stroke interventional trials : recanalization versus reperfusion in IMS-I", Stroke, 36, pp.2400~2403 (2005)
  93. TIMI Study Group., "The Thrombolysis in Myocardial Infarction(TIMI)trial. Phase I findings", N Engl J Med, 312, pp.932~936 (1985)
  94. Furlan A., "Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism", JAMA, 282, pp.2003~2011 (1999)
  95. Marks MP., "Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke", Stroke, 45, pp.1035~1039 (2014)
  96. Cho KH., "Early infarct growth predicts long-term clinical outcome after thrombolysis", J Neurol Sci, 316, pp.99~103 (2012)
  97. Marks MP, "Correlation of AOL recanalization, TIMI reperfusion and TICI reperfusion with infarct growth and clinical outcome", J Neurointerv Surg (2013)
  98. Singer OC., "Practical limitations of acute stroke MRI due to patient-related problems", Neurology, 62, pp.1848~1849 (2004)
  99. Yoo SH., "Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke", J Neurol Sci, 294, pp.119~123 (2010)
  100. Chalela JA., "Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke : a prospective comparison", Lancet, 369, pp.293~298 (2007)
  101. Merino JG., "Imaging of acute stroke", Nat Rev Neurol, 6, pp.560~571 (2010)
  102. Kang DW., "MRI screening before standard tissue plasminogen activator therapy is feasible and safe", Stroke, 36, pp.1939~1943 (2005)
  103. Nael K., "Six-minute magnetic resonance imaging protocol for evaluation of acute ischemic stroke : pushing the boundaries", Stroke, 45, pp.1985~1991 (2014)

관련 논문AI추천

Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular TherapyBruce C.V. Campbell, James E. Siegler, Jin Soo Lee, Mohamad Abdalkader, Shadi Yaghi, Thanh N. Nguyen, Xiaochuan Huo, Zhongming Qiu, Zhongrong Miao대한뇌졸중학회 · 대한뇌졸중영문학회지2023 · 제25권 제1호Direct Thrombus Imaging in Stroke김동억, 김종성, 박정이, Matthias Nahrendorf대한뇌졸중학회 · 대한뇌졸중영문학회지2016 · 제18권 제3호Fast MRI in Acute Ischemic Stroke: Applications of MRI Acceleration Techniques for MR-Based Comprehensive Stroke Imaging김병준, Bo Kyu Kim, Sang Eun Park, Sung-Hye You대한자기공명의과학회 · Investigative Magnetic Resonance Imaging2021 · 제25권 제2호Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies방오영대한신경과학회 · Journal of Clinical Neurology2009 · 제5권 제3호Computed Tomography-Based Thrombus Imaging for the Prediction of Recanalization after Reperfusion Therapy in Stroke김견섭, 김영대, 김응엽, 남효석, 유준상, 허지회대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제1호Choosing a Hyperacute Stroke Imaging Protocol for Proper Patient Selection and Time Efficient Endovascular Treatment: Lessons from Recent TrialsAndrew M. Demchuk, Jin Soo Lee대한뇌졸중학회 · 대한뇌졸중영문학회지2015 · 제17권 제3호

이 간행물의 다른 논문 (12건)

Research on Intracranial Atherosclerosis from the East and West: Why Are the Results Different?David Bonovich, 김종성pp. 105-113Stroke Genetics: A Review and UpdateArne Lindgrenpp. 114-123Isolated Vascular Vertigo이형pp. 124-130Critical Care for Patients with Massive Ischemic Stroke고윤석, H. Alex Choi, 전상범, 이기원pp. 146-160MRI-based Algorithm for Acute Ischemic Stroke Subtype Classification신동익, 이경복, 이수주, 김동억, 배희준, 차재관, 한문구, 강규식, 홍근식, 고영채, 이준영, 유경호, 이병철, 김대현, 이준, 김준태, 조용진, 정종원, 이지성, 최재철, 박상순, 박종무, 박태환pp. 161-172
원문 보기